Quantification and analysis of thymidine kinase expression from acyclovir-resistant G-String insertion and deletion mutants in herpes simplex virus-infected cells

Journal of Virology

Volumn 86, Issue 8, 2012, Pages 4518-4526

  Pan, Dongli ^a   Coen, Donald M ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; EPITOPE; GUANINE DERIVATIVE; MESSENGER RNA; POLYPEPTIDE; THYMIDINE KINASE;

ARTICLE; AUTORADIOGRAPHY; CONTROLLED STUDY; ENZYME ACTIVITY; FRAMESHIFT MUTATION; GENE EXPRESSION; HERPES SIMPLEX; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; INDEL MUTATION; LATENT PERIOD; MOLECULAR DYNAMICS; NONHUMAN; NONSENSE MUTATION; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RNA PROBE; RNA SEQUENCE; SENSITIVITY ANALYSIS; SEQUENCE ANALYSIS; STOP CODON; THYMIDINE KINASE GENE; VIRUS GENE; VIRUS RESISTANCE; WESTERN BLOTTING; WILD TYPE;

ACYCLOVIR; AMINO ACID SEQUENCE; ANIMALS; ANTIVIRAL AGENTS; BASE SEQUENCE; CELL LINE; CERCOPITHECUS AETHIOPS; CODON, NONSENSE; DRUG RESISTANCE, VIRAL; FRAMESHIFT MUTATION; GENE DELETION; GENE EXPRESSION; GENE ORDER; HUMANS; MUTAGENESIS, INSERTIONAL; MUTATION; PROTEIN STABILITY; SIMPLEXVIRUS; THYMIDINE KINASE;

MUS; SIMPLEXVIRUS;

EID: 84861396337     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.06995-11     Document Type: Article

References (31)

1. Besecker MI, Furness CL, Coen DM, Griffiths A. 2007. Expression of extremely low levels of thymidine kinase from an acyclovir-resistant herpes simplex virus mutant supports reactivation from latently infected mouse trigeminal ganglia. J. Virol. 81:8356-8360.
2. Burrel S, Deback C, Agut H, Boutolleau D. 2010. Genotypic characterization of UL23 thymidine kinase and UL30 DNA polymerase of clinical isolates of herpes simplex virus: natural polymorphism and mutations associated with resistance to antivirals. Antimicrob. Agents Chemother. 54:4833-4842.
3. Chen SH, Cook WJ, Grove KL, Coen DM. 1998. Human thymidine kinase can functionally replace herpes simplex virus type 1 thymidine kinase for viral replication in mouse sensory ganglia and reactivation from latency upon explant. J. Virol. 72:6710-6715.
4. Chen SH, Pearson A, Coen DM. 2004. Failure of thymidine kinasenegativeherpes simplex virus to reactivate from latency following efficient establishment. J. Virol. 78:520-523.
5. Chibo D, Druce J, Sasadeusz J, Birch C. 2004. Molecular analysis of clinical isolates of acyclovir resistant herpes simplex virus. Antiviral Res. 61:83-91.
6. Coen DM, Irmiere AF, Jacobson JG, Kerns KM. 1989. Low levels of herpes simplex virus thymidine-thymidylate kinase are not limiting for sensitivity to certain antiviral drugs or for latency in a mouse model. Virology 168:221-231.
7. Coen DM, et al. 1989. Thymidine kinase-negative herpes simplex virus mutants establish latency in mouse trigeminal ganglia but do not reactivate. Proc. Natl. Acad. Sci. U. S. A. 86:4736-4740.
8. Coen DM, Weinheimer SP, McKnight SL. 1986. A genetic approach to promoter recognition during trans induction of viral gene expression. Science 234:53-59.
9. Danve-Szatanek C, et al. 2004. Surveillance network for herpes simplex virus resistance to antiviral drugs: 3-year follow-up. J. Clin. Microbiol. 42:242-249.
10. Efstathiou S, Kemp S, Darby G, Minson AC. 1989. The role of herpes s3.implex virus type 1 thymidine kinase in pathogenesis. J. Gen. Virol. 70: 869-879.
11. Gaudreau A, Hill E, Balfour HH, Jr, Erice A, Boivin G. 1998. Phenotypic and genotypic characterization of acyclovir-resistant herpes simplex viruses from immunocompromised patients. J. Infect. Dis. 178:297-303.
12. Grey F, et al. 2003. Characterization of a neurovirulent aciclovir-resistant variant of herpes simplex virus. J. Gen. Virol. 84:1403-1410.
13. Griffiths A. 2011. Slipping and sliding: frameshift mutations in herpes simplex virus thymidine kinase and drug-resistance. Drug Resist. Updat. 14:251-259.
14. Griffiths A, Chen SH, Horsburgh BC, Coen DM. 2003. Translational compensation of a frameshift mutation affecting herpes simplex virus thymidine kinase is sufficient to permit reactivation from latency. J. Virol. 77:4703-4709.
15. Griffiths A, Coen DM. 2005. An unusual internal ribosome entry site in the herpes simplex virus thymidine kinase gene. Proc. Natl. Acad. Sci. U. S. A. 102:9667-9672.
16. Griffiths A, Coen DM. 2003. High-frequency phenotypic reversion and pathogenicity of an acyclovir-resistant herpes simplex virus mutant. J. Virol. 77:2282-2286.
17. Griffiths A, Link MA, Furness CL, Coen DM. 2006. Low-level expression and reversion both contribute to reactivation of herpes simplex virus drug-resistant mutants with mutations on homopolymeric sequences in thymidine kinase. J. Virol. 80:6568-6574.
18. Horsburgh BC, et al. 1998. Recurrent acyclovir-resistant herpes simplex in an immunocompromised patient: can strain differences compensate for loss of thymidine kinase in pathogenesis? J. Infect. Dis. 178:618-625.
19. Horsburgh BC, Kollmus H, Hauser H, Coen DM. 1996. Translational recoding induced by G-rich mRNA sequences that form unusual structures. Cell 86:949-959.
20. Hwang CB, et al. 1994. A net +1 frameshift permits synthesis of thymidine kinase from a drug-resistant herpes simplex virus mutant. Proc. Natl. Acad. Sci. U. S. A. 91:5461-5465.
21. Irmiere AF, Manos MM, Jacobson JG, Gibbs JS, Coen DM. 1989. Effect of an amber mutation in the herpes simplex virus thymidine kinase gene on polypeptide synthesis and stability. Virology 168:210-220.
22. Jacobson JG, Martin SL, Coen DM. 1989. A conserved open reading frame that overlaps the herpes simplex virus thymidine kinase gene is important for viral growth in cell culture. J. Virol. 63:1839-1843.
23. Morfin F, et al. 2004. HSV excretion after bone marrow transplantation: a 4-year survey. J. Clin. Virol. 30:341-345.
24. Muhlrad D, Parker R. 1999. Recognition of yeast mRNAs as "nonsense containing" leads to both inhibition of mRNA translation and mRNA degradation: implications for the control of mRNA decapping. Mol. Biol. Cell 10:3971-3978.
25. Sasadeusz JJ, Sacks SL. 1996. Spontaneous reactivation of thymidine kinase-deficient, acyclovir-resistant type-2 herpes simplex virus: masked eterogeneity or reversion? J. Infect. Dis. 174:476-482.
26. Sasadeusz JJ, et al. 1997. Homopolymer mutational hot spots mediate herpes simplex virus resistance to acyclovir. J. Virol. 71:3872-3878.
27. Sauerbrei A, Deinhardt S, Zell R, Wutzler P. 2010. Phenotypic and genotypic characterization of acyclovir-resistant clinical isolates of herpes simplex virus. Antiviral Res. 86:246-252.
28. Stranska R, et al. 2005. Survey of acyclovir-resistant herpes simplex virus in the Netherlands: prevalence and characterization. J. Clin. Virol. 32:7-18.
29. Tenser RB, Edris WA. 1987. Trigeminal ganglion infection by thymidine kinase-negative mutants of herpes simplex virus after in vivo complementation. J. Virol. 61:2171-2174.
30. Tenser RB, Miller RL, Rapp F. 1979. Trigeminal ganglion infection by thymidine kinase-negative mutants of herpes simplex virus. Science 205: 915-917.
31. Tischer BK, von Einem J, Kaufer B, Osterrieder N. 2006. Two-step Red-mediated recombination for versatile high-efficiency markerless DNA manipulation in Escherichia coli. Biotechniques 40:191-197.